Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,390.00 at Bank of America

Mettler-Toledo International (NYSE:MTD) had its target price lifted by Bank of America from $1,260.00 to $1,390.00 in a research note released on Monday,Benzinga reports. They currently have a neutral rating on the medical instruments supplier’s stock.

Other equities analysts also recently issued reports about the company. Citigroup increased their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Barclays assumed coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They set an “overweight” rating and a $1,325.00 target price for the company. Robert W. Baird increased their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Finally, Evercore ISI cut their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating for the company in a research note on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of “Moderate Buy” and a consensus price target of $1,325.56.

Mettler-Toledo International Stock Down 0.6%

Shares of MTD stock opened at $1,257.79 on Monday. The stock has a market capitalization of $25.91 billion, a PE ratio of 31.85, a price-to-earnings-growth ratio of 3.79 and a beta of 1.37. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,521.01. The stock’s 50-day moving average price is $1,266.00 and its 200 day moving average price is $1,184.96.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to analysts’ expectations of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider owned 94 shares of the company’s stock, valued at $123,012.16. This represents a 63.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,827 shares of company stock worth $2,371,208. 0.77% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in MTD. WPG Advisers LLC purchased a new position in shares of Mettler-Toledo International during the 1st quarter worth $41,000. NewSquare Capital LLC lifted its stake in shares of Mettler-Toledo International by 94.4% during the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after purchasing an additional 17 shares during the period. MV Capital Management Inc. lifted its stake in shares of Mettler-Toledo International by 50.0% during the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 12 shares during the period. Zions Bancorporation National Association UT purchased a new position in shares of Mettler-Toledo International during the 1st quarter worth $43,000. Finally, Golden State Wealth Management LLC lifted its stake in shares of Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock worth $48,000 after purchasing an additional 35 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.